XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

5. Stock-Based Compensation

Stock-based compensation includes expense charges for all stock-based awards to employees and directors. These awards include stock option grants and restricted stock awards.

Stock-based compensation expense related to internal labor is capitalized to software and patent costs based on direct labor hours charged to capitalized software and patent costs.

Determining Fair Value

Stock Options

Valuation and Amortization Method. The Company estimates the fair value of stock options on the date of grant (measurement date) using the Black-Scholes option valuation model. The Company amortizes the fair value of all awards on a straight-line basis over the requisite service periods, which are generally the vesting periods.

Expected Life. The expected life of awards granted represents the period of time that they are expected to be outstanding. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms and vesting schedules of the awards. Stock options granted generally vest over three years and have contractual terms of ten years.

Expected Volatility. The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of its common stock based on historical prices over the most recent period commensurate with the expected life of the award.

Risk-Free Interest Rate. The Company determines the risk-free interest rate using current U.S. treasury yields for bonds with a maturity commensurate with the expected life of the award.

Expected Dividend Yield. The expected dividend yield is derived by the Company’s expected annual dividend rate over the expected term divided by the fair value of the Company’s common stock at the grant date.

There were no stock options granted during the six months ended June 30, 2019 and 2018.

Restricted Stock

The fair value of restricted stock awarded is based on the fair market value of the Company’s common stock on the date of the grant (measurement date) and is recognized over the vesting period of the award using the straight-line method. Restricted stock awards granted generally vest over three to four years for employee grants and one to three years for director grants.

Stock-Based Compensation

 

 

 

Three

 

 

Three

 

 

Six

 

 

Six

 

 

 

Months

 

 

Months

 

 

Months

 

 

Months

 

 

 

Ended

 

 

Ended

 

 

Ended

 

 

Ended

 

 

 

June 30,

 

 

June 30,

 

 

June 30,

 

 

June 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

179

 

 

$

167

 

 

$

361

 

 

$

322

 

Sales and marketing

 

 

489

 

 

 

411

 

 

 

1,008

 

 

 

756

 

Research, development and engineering

 

 

357

 

 

 

350

 

 

 

711

 

 

 

648

 

General and administrative

 

 

927

 

 

 

814

 

 

 

1,839

 

 

 

1,615

 

Intellectual property

 

 

64

 

 

 

67

 

 

 

134

 

 

 

139

 

Stock-based compensation expense

 

 

2,016

 

 

 

1,809

 

 

 

4,053

 

 

 

3,480

 

Capitalized to software and patent costs

 

 

49

 

 

 

49

 

 

 

90

 

 

 

93

 

Total stock-based compensation

 

$

2,065

 

 

$

1,858

 

 

$

4,143

 

 

$

3,573

 

 

The following table sets forth total unrecognized compensation cost related to non-vested stock-based awards granted under all equity compensation plans:

 

 

 

As of

 

 

As of

 

 

 

June 30,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Total unrecognized compensation costs

 

$

15,205

 

 

$

14,055

 

 

Total unrecognized compensation costs will be adjusted for any future forfeitures if and when they occur.

The Company expects to recognize the total unrecognized compensation costs as of June 30, 2019 for stock options and restricted stock over weighted average periods through June 30, 2023 as follows:

 

 

 

Stock

 

Restricted

 

 

Options

 

Stock

Weighted average period

 

0.99 years

 

1.53 years

 

As of June 30, 2019, under all of the Company’s stock-based compensation plans, equity awards to purchase an additional 1,388 shares were authorized for future grants under the plans. The Company issues new shares upon option exercises.

Stock Option Activity

The following table reconciles the outstanding balance of stock options:

 

 

 

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Grant Date

 

 

Intrinsic

 

Three months ended June 30, 2019:

 

Options

 

 

Price

 

 

Fair Value

 

 

Value

 

Outstanding at March 31, 2019

 

 

503

 

 

$

28.89

 

 

$

13.26

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(13

)

 

 

14.99

 

 

 

8.12

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2019

 

 

490

 

 

$

29.26

 

 

$

13.40

 

 

$

7,414

 

 

 

 

 

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Grant Date

 

 

Intrinsic

 

Six months ended June 30, 2019:

 

Options

 

 

Price

 

 

Fair Value

 

 

Value

 

Outstanding at December 31, 2018

 

 

513

 

 

$

28.52

 

 

$

13.10

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(23

)

 

 

12.77

 

 

 

6.81

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2019

 

 

490

 

 

$

29.26

 

 

$

13.40

 

 

$

7,414

 

Exercisable at June 30, 2019

 

 

332

 

 

$

28.88

 

 

 

 

 

 

$

5,144

 

Unvested at June 30, 2019

 

 

158

 

 

$

30.05

 

 

 

 

 

 

$

2,270

 

 

The aggregate intrinsic value is based on the closing price of $44.39 per share of Digimarc common stock on June 28, 2019, the last trading day before the end of the second fiscal quarter, which would have been received by the optionees had all of the options with exercise prices less than $44.39 per share been exercised on that date.

Restricted Stock Activity

The following table reconciles the unvested balance of restricted stock:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

Three months ended June 30, 2019:

 

Shares

 

 

Fair Value

 

Unvested balance, March 31, 2019

 

 

628

 

 

$

26.59

 

Granted

 

 

18

 

 

$

32.75

 

Vested

 

 

(76

)

 

$

27.61

 

Forfeited

 

 

(45

)

 

$

27.13

 

Unvested balance, June 30, 2019

 

 

525

 

 

$

26.61

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

Six months ended June 30, 2019:

 

Shares

 

 

Fair Value

 

Unvested balance, December 31, 2018

 

 

426

 

 

$

28.85

 

Granted

 

 

273

 

 

$

23.93

 

Vested

 

 

(128

)

 

$

28.13

 

Forfeited

 

 

(46

)

 

$

27.13

 

Unvested balance, June 30, 2019

 

 

525

 

 

$

26.61

 

 

The following table indicates the fair value of all restricted stock awards that vested:

 

 

 

Three

 

 

Three

 

 

Six

 

 

Six

 

 

 

Months

 

 

Months

 

 

Months

 

 

Months

 

 

 

Ended

 

 

Ended

 

 

Ended

 

 

Ended

 

 

 

June 30,

 

 

June 30,

 

 

June 30,

 

 

June 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Fair value of restricted stock awards vested

 

$

3,992

 

 

$

2,016

 

 

$

5,232

 

 

$

3,272